InvestorsHub Logo
Followers 18
Posts 1300
Boards Moderated 0
Alias Born 04/09/2010

Re: None

Thursday, 07/13/2017 3:37:40 PM

Thursday, July 13, 2017 3:37:40 PM

Post# of 64409

Throughout 2017, we expect to continue actively marketing Nyloxin® and Pet Pain-AwayTM as well as beginning sales of Nyloxin® Military Strength. It is our goal to begin broad retail sales of our OTC products and get Nyloxin® and Pet Pain-Away into retail stores by the end of 2017. These sales will bring in the revenue that will bring the company to profitability as well as provide the financing for the proposed clinical studies. We have worked diligently with our partners to move the registration process forward in Canada. We have also worked with distributors in Mexico, Spain and Israel. All of these markets should provide revenue growth throughout 2017.



http://www.nutrapharma.com/Dec2016_shareholder_letter.pdf